Can a common ADHD drug truly sharpen a healthy mind? a trial puts it to the test

NCT ID NCT07742631

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial asks whether methylphenidate, a stimulant used for ADHD, can actually improve thinking, exercise capacity, balance, and heart safety in healthy adults without ADHD. About 30 healthy volunteers aged 18 to 50 will take either the drug or a placebo for 14 days, then switch after a break. Researchers will measure attention, oxygen use during exercise, heart rhythm, and muscle strength to see if the drug offers any real benefit beyond a placebo effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Extended-release methylphenidate (a stimulant medication) taken as 20 mg capsules once daily for 14 days, compared with an inert placebo.
What this could lead to
If it works, this could clarify whether methylphenidate truly boosts mental or physical performance in healthy people, or if the perceived benefits are mostly placebo effects.
What could go wrong
This is a small, early-phase trial in healthy volunteers, so results may not apply to real-world use. Methylphenidate can raise heart rate and blood pressure, and its cognitive benefits in non-ADHD adults remain unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE AND FEMALE VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of the Witwatersrand

    Johannesburg, Gauteng, 2193, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.